Immune mediated neuropathies: An update on therapeutic strategiesCZAPLINSKI, Adam; STECK, Andreas J.Journal of neurology. 2004, Vol 251, Num 2, pp 127-137, issn 0340-5354, 11 p.Article

Amyotrophic lateral sclerosis : early predictors of prolonged survivalCZAPLINSKI, Adam; YEN, Albert A; APPEL, Stanley H et al.Journal of neurology. 2006, Vol 253, Num 11, pp 1428-1436, issn 0340-5354, 9 p.Article

Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis : Is the natural history of amyotrophic lateral sclerosis changing?CZAPLINSKI, Adam; YEN, Albert A; SIMPSON, Ericka P et al.Archives of neurology (Chicago). 2006, Vol 63, Num 8, pp 1139-1143, issn 0003-9942, 5 p.Article

Predictability of disease progression in amyotrophic lateral sclerosisCZAPLINSKI, Adam; YEN, Albert A; SIMPSON, Ericka P et al.Muscle & nerve. 2006, Vol 34, Num 6, pp 702-708, issn 0148-639X, 7 p.Article

Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)LIZROVA PREININGEROVA, Jana; BAUMHACKL, Ulf; LEDINEK, Alenka Horvath et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 5, pp 302-306, issn 1755-5930, 5 p.Article

ALSFRS AND APPEL ALS SCORES : DISCORDANCE WITH DISEASE PROGRESSIONVOUSTIANIOUK, Andrei; SEIDEL, Gregory; PANCHAL, Janki et al.Muscle & nerve. 2008, Vol 37, Num 5, pp 668-672, issn 0148-639X, 5 p.Article

IgM deposits on skin nerves in anti- myelin-associated glycoprotein neuropathyLOMBARDI, Raffaella; ERNE, Beat; STECK, Andreas J et al.Annals of neurology. 2005, Vol 57, Num 2, pp 180-187, issn 0364-5134, 8 p.Article